Northland Pharmaceuticals: Holding subsidiary Haichang Pharmaceuticals passed the GMP certification of the National Health Surveillance Agency in Brazil.

Northland Pharmaceutical announced that its holding subsidiary Zhejiang Haichang Pharmaceutical Co., Ltd. recently passed the on-site GMP certification of the National Health Surveillance Agency of Brazil, with the certification scope covering iodohexanol. This certification creates conditions for Haichang Pharmaceutical products to successfully enter the Brazilian market, laying a solid foundation for further expanding the Brazilian market and other international markets, which is of positive significance for the overall internationalization strategy of the group. However, the sales of pharmaceutical products are subject to uncertainties such as national policies, market environment, etc., and there are significant uncertainties. Investors are advised to make decisions cautiously and pay attention to investment risks.